# Acella Pharmaceuticals, LLC - Inspection Records

Source: https://www.keypedia.com/companies/acella-pharmaceuticals-llc/95727716-8bc6-4b45-8f0b-2c018ea7f296

> Inspection records and compliance data for Acella Pharmaceuticals, LLC in Alpharetta, Georgia. Access full analysis and detailed observations.

---

## Details

- Name: Acella Pharmaceuticals, LLC
- FEI Number: 3006691461
- City: Alpharetta
- State: Georgia
- Country Name: United States
- Address Line 1: 1880 Mcfarland Pkwy Ste 110
- Zip Code: 30005

## Related Documents

- [483 - Acella Pharmaceuticals, LLC - 2024-12-18](https://www.keypedia.com/records/483/acella-pharmaceuticals-llc/7c5ae9dd-2945-4d76-8669-e2a1fbcf43b3) — source: FDA, date: December 18, 2024
- [FDA Inspection 1232099 - Acella Pharmaceuticals, LLC - 2024-12-18](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/ea9b7cdd-5b50-4496-856d-90fd6d1655be) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2024
- [FDA Inspection 1232099 - Acella Pharmaceuticals, LLC - 2024-12-18](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/a22b7794-7b4a-4ac6-8901-c70734a40c3a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2024
- [483 - Acella Pharmaceuticals, LLC - 2023-02-10](https://www.keypedia.com/records/483/acella-pharmaceuticals-llc/a47ff318-a2b1-4547-8be6-ff4e3ddff1b5) — source: FDA, date: February 10, 2023
- [FDA Inspection 1197977 - Acella Pharmaceuticals, LLC - 2023-02-10](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/91bf22b1-c467-4d2f-9868-9300f0fee498) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 10, 2023
- [483 - Acella Pharmaceuticals, LLC - 2021-09-17](https://www.keypedia.com/records/483/acella-pharmaceuticals-llc/b7225615-5386-4ced-8ce5-2efa60c37d5e) — source: FDA, date: September 17, 2021
- [FDA Inspection 1152922 - Acella Pharmaceuticals, LLC - 2021-09-17](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/830bb53d-854f-43a4-9743-9247044c9ca5) — classification: Official Action Indicated (OAI), source: FDA, date: September 17, 2021
- [483 - Acella Pharmaceuticals, LLC - 2020-01-07](https://www.keypedia.com/records/483/acella-pharmaceuticals-llc/6188daa7-af89-4c87-b4d2-e63014b71d59) — source: FDA, date: January 7, 2020
- [WARNING_LETTER - Acella Pharmaceuticals, LLC - 2020-01-07](https://www.keypedia.com/records/warning_letter/acella-pharmaceuticals-llc/65e0ddf5-ebd7-4a30-9f88-ce5bdb9a6402) — source: FDA, date: January 7, 2020
- [FDA Inspection 1115488 - Acella Pharmaceuticals, LLC - 2020-01-07](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/6b594528-6f59-4fe3-b0ed-1b0264f258f7) — classification: Official Action Indicated (OAI), source: FDA, date: January 7, 2020
- [483 - Acella Pharmaceuticals, LLC - 2019-03-29](https://www.keypedia.com/records/483/acella-pharmaceuticals-llc/701617cb-61e5-4e67-a13b-84fc6fd5151b) — source: FDA, date: March 29, 2019
- [EIR - Acella Pharmaceuticals, LLC - 2019-03-29](https://www.keypedia.com/records/eir/acella-pharmaceuticals-llc/cb1f9e55-2e6c-4e53-a434-cb3b36203f29) — source: FDA, date: March 29, 2019
- [FDA Inspection 1085822 - Acella Pharmaceuticals, LLC - 2019-03-29](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/c4aa737c-7804-4d1a-805b-ec94a1b10c38) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2019
- [EIR - Acella Pharmaceuticals, LLC - 2017-03-08](https://www.keypedia.com/records/eir/acella-pharmaceuticals-llc/9c7922da-4f15-489d-93be-82bbb6994aca) — source: FDA, date: March 8, 2017
- [FDA Inspection 1014708 - Acella Pharmaceuticals, LLC - 2017-03-08](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/ac65f52f-03de-4b96-9345-4bca54cd5890) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 8, 2017
- [FDA Inspection 947620 - Acella Pharmaceuticals, LLC - 2015-10-28](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/4842a492-f881-44e9-ad2d-df7f40ab8896) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 28, 2015
- [FDA Inspection 947620 - Acella Pharmaceuticals, LLC - 2015-10-28](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/7cce95af-d274-4c1b-9187-a62727398bcc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 28, 2015
- [FDA Inspection 897316 - Acella Pharmaceuticals, LLC - 2014-09-10](https://www.keypedia.com/records/fda_inspections/acella-pharmaceuticals-llc/ce88a126-c745-456f-8288-c2564f77d372) — classification: No Action Indicated (NAI), source: FDA, date: September 10, 2014

## Related Companies

- [Avion Pharmaceuticals, LLC](https://www.keypedia.com/companies/avion-pharmaceuticals-llc/c909aea3-b381-4105-86ee-9f7260b10a06)
- [Homeocare Laboratories, Inc.](https://www.keypedia.com/companies/homeocare-laboratories-inc/c4464988-ca0b-4146-b817-3dfb461a073e)
- [Nitro Quimica Corporation dba Alchemix A Nitro Quimica Corporation](https://www.keypedia.com/companies/nitro-quimica-corporation-dba-alchemix-a-nitro-quimica-corporation/a2c8391c-ef9e-4769-a7fc-5a0c0431baf1)
- [Owen Biosciences Inc.](https://www.keypedia.com/companies/owen-biosciences-inc/a884ad6d-40ba-4df7-8385-49f52b3dff62)
- [B & J Group](https://www.keypedia.com/companies/b-j-group/d182d7fa-aaf8-48b6-88fa-11beafc5345e)
- [J.M. Murray Center, Inc.](https://www.keypedia.com/companies/jm-murray-center-inc/c8ea2d08-6e27-4aab-956c-49bafd74acf7)
- [AptaPharma Inc.](https://www.keypedia.com/companies/aptapharma-inc/8390ea00-697d-4f5d-9e50-407830a6b2ee)
- [Axia Medical Solutions, LLC](https://www.keypedia.com/companies/axia-medical-solutions-llc/7f3ae1e2-01ba-4501-8bcb-06df88a1d798)
- [ADMA Biologics, Inc](https://www.keypedia.com/companies/adma-biologics-inc/dcb996fb-4a71-44fe-87f1-cfe3979d4182)
- [WELSCO, INC.](https://www.keypedia.com/companies/welsco-inc/49aff57b-6fe6-434b-9fd3-df94c9bb7cfc)

## Related Officers

- [company_representative](https://www.keypedia.com/people/sharon-leyva/29699e20-86e1-4dc3-86a6-c6428c8b8f32)
- [Consumer Safety](https://www.keypedia.com/people/joseph-f-owens/68cda862-335d-4de4-8abd-bf83a96a76bb)
- [recipient](https://www.keypedia.com/people/becky-clasper/41d4f514-0b7d-4b58-a7c2-14f47e995928)
- [Matthew R. Coleman](https://www.keypedia.com/people/matthew-r-coleman/6fc13ec4-a609-4c3c-961f-16cba13a3a3a)